Showing results (1171-1180 of 1,207) with videos related to

Sort By:
Pageof 121
Lancet Regional Health. Americas|August 8, 2022
Risk factors for severe COVID-19 in hospitalized children in Canada: A national prospective study from March 2020-May 2021Daniel S Farrar, Olivier Drouin, Charlotte Moore Hepburn, et al.
The Pediatric Infectious Disease Journal|January 30, 2022
Clinical Presentations and Outcomes of Children in Canada With Recurrent Invasive Pneumococcal Disease From the IMPACT Surveillance NetworkYousif Murad, Te-Yu Hung, Manish Sadarangani, et al.
BMJ (Clinical Research Ed.)|September 15, 2016
Prevalence of microcephaly in Europe: population based studyJoan K Morris, Judith Rankin, Ester Garne, et al.
Archives of Disease in Childhood|June 28, 2019
Epidemiology of congenital cerebral anomalies in Europe: a multicentre, population-based EUROCAT studyJoan K Morris, Diana G Wellesley, Ingeborg Barisic, et al.
Journal of Medicinal Chemistry|March 28, 1997
Structure-based design of nonpeptidic HIV protease inhibitors: the sulfonamide-substituted cyclooctylpyramonesH I Skulnick, P D Johnson, P A Aristoff, et al.
BMJ Public Health|July 15, 2025
Severe infection incidence among young infants in Dhaka, Bangladesh: an observational cohort studyAlastair Fung, Cole Heasley, Lisa G Pell, et al.
The Journal of Clinical Investigation|August 1, 2024
Human milk antibodies to global pathogens reveal geographic and interindividual variations in IgA and IgGJoseph J Campo, Antti E Seppo, Arlo Z Randall, et al.
The Lancet. Gastroenterology & Hepatology|March 16, 2025
Software-based versus visual assessment of the minimal ablative margin in patients with liver tumours undergoing percutaneous thermal ablation (COVER-ALL): a randomised phase 2 trialBruno C Odisio, Jessica Albuquerque, Yuan-Mao Lin, et al.
JCO Precision Oncology|March 6, 2025
Incorporating Circulating Tumor DNA Testing Into Clinical Trials: A Position Paper by the National Cancer Institute GI Oncology Circulating Tumor DNA Working GroupLakshmi Rajdev, Gentry G King, Christopher H Lieu, et al.
Journal for Immunotherapy of Cancer|July 22, 2024
First-in-human dose escalation trial to evaluate the clinical safety and efficacy of an anti-MAGEA1 autologous TCR-transgenic T cell therapy in relapsed and refractory solid tumorsMartin Wermke, Tobias A W Holderried, Jason John Luke, et al.
Pageof 121